BRNS: Barinthus Biotherapeutics PLC Kompaniya qiymatining sof foydaga nisbati

Barinthus Biotherapeutics Corp - BRNS emitenti grafik logotipi

Barinthus Biotherapeutics (BRNS) uchun xos bo'lgan P/E koeffitsiyenti -0.70 darajasida bo'lib, bu AQSh va Buyuk Britaniyada HPV va hepatit B ga qarshi vaksinalarni ishlab chiqayotgan markazlarning faoliyati bilan bog'liq. Ushbu tendentsiya tseliakiya kasalligi terapiyasi uchun VTP platformasining joriy etilishi va pipeline yangilanishlarining agressiv ravishda amalga oshirilishi bilan qo'llab-quvvatlanmoqda. Biznes T-hujayralar terapiyasini yaratishda bioetika va boshqaruv shaffofligiga rioya qilgan holda, "yashil kimyo" tamoyillariga tayanadi.

Barinthus Biotherapeutics plc (BRNS) Narxning foydaga nisbati: 21.02.2024 - 19.09.2026 davri uchun

Barinthus Biotherapeutics Corp (BRNS) kompaniyasining tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning har tomonlama tahlili:Barinthus Biotherapeutics plc BRNS
Barinthus Bio brend mahsuloti

P/E koeffitsiyenti sof foydaning bir birligining bozor qiymatini belgilaydi, bu esa investorga bozor kapitalizatsiyasini haqiqiy daromadlar bilan solishtirish orqali aktiv uchun haddan tashqari ko'p to'lov darajasini va "qiymat tuzog'i" xavfini baholash imkonini beradi. Joriy P/E baholash darajasini tahlil qilish Barinthus Biotherapeutics (BRNS) uchun juda muhimdir, chunki u T-hujayrali saraton vaksinalari sohasidagi ekspert ishlanmalarini monetizatsiya qilish bo'yicha bozor kutganlarini aks ettiradi.

Muhim raqobatchilar

P/E multiplikatori Argenx|Narx-foyda koeffitsiyenti BNTX (BioNTech Group)|ABVX (abivax.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (admabiologics.com)|Biznesning o‘zini qoplash muddati protagonist-inc.com (PTGX)|IMVT - Narxning foydaga nisbati|Kiniksa Pharmaceuticals, Ltd. (KNSA) - Narx-foyda koeffitsiyenti|Grifols Biemat (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotechnologies|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori auriniapharma.com|Narxning foydaga nisbati BioCryst Pharmaceuticals Inc (BCRX)|Vera Therapeutics - Narx-foyda multiplikatori|P/E multiplikatori DNTH (dianthustx.com)|Pharvaris Pharma (PHVS) - Kapitalizatsiyaning foydaga nisbati|AbCellera Biologics - P/E multiplikatori|tourmalinebio.com - Bozor narxining sof foydaga nisbati|Precigen (PGEN) - Narxning foydaga nisbati|Pharming Group - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Nektar Therapeutics Inc|UPB (Upstream Pharma) - Bozor narxining sof foydaga nisbati|P/E multiplikatori ZBIO|P/E multiplikatori immunome.com (IMNM)|P/E multiplikatori GOSS (gossamerbio.com)|Biznesning o‘zini qoplash muddati KalVista Pharma (KALV)|SEPN - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Pieris Pharmaceuticals PVLA|SVRA (Savara Inc.) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning sof foydaga nisbati RIGL (Rigel Pharmaceuticals)|ANAB (AnaptysBio) - P/E multiplikatori|ATXS (Astria Therapeutics, Inc.) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati engene.com (ENGN)|RAPT (RAPT Therapeutics, Inc.) - Kompaniya qiymatining sof foydaga nisbati|Aerovate Therapeutics - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati ACRS|Kyverna Therapeutics, Inc - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati TLSA|CABA: P/E multiplikatori|Narx-foyda koeffitsiyenti Ventyx Bio|Narxning foydaga nisbati Theratechnologies, Inc.|Kapitalizatsiyaning foydaga nisbati Avalo Therapeutics AVTX|P/E multiplikatori ELDN|AGEN (Agenus, Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Climb Bio, Inc. CLYM|Zura Bio Limited (ZURA) - Kapitalizatsiyaning foydaga nisbati|ATYR: Narx-foyda koeffitsiyenti|adagene.com (ADAG) - Narx-foyda koeffitsiyenti|Ikena Oncology (IMA) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Shattuck Labs, Inc.|Narxning foydaga nisbati equilliumbio.com|Narx-foyda koeffitsiyenti connectbiopharm.com (CNTB)|P/E multiplikatori IMUX|Biznesning o‘zini qoplash muddati Atara Bio|Narxning foydaga nisbati InflaRx N.V. IFRX|X4 Pharmaceuticals - Narxning foydaga nisbati|ACET: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati CELU (celularity.com)|INMB: P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati KZR (Kezar Life Sciences)|Narxning foydaga nisbati SAB Biotherapeutics Inc.|Akari Therapeutics Plc - Kapitalizatsiyaning sof foydaga nisbati|Narx-foyda koeffitsiyenti ENLV (Enlivex Therapeutics Ltd.)|Narx-foyda koeffitsiyenti Q32 Bio Inc QTTB|Narxning foydaga nisbati geovax.com GOVX|P/E multiplikatori edesabiotech.com EDSA|iBio Corporation - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati CARM (carismatx.com)|XTL Biopharmaceuticals Ltd. (XTLB) - Narxning foydaga nisbati|Bolt Bio (BOLT) - P/E multiplikatori|HCWB (HCW Biologics Inc) - P/E multiplikatori|Narx-foyda koeffitsiyenti Aptevo Therapeutics (APVO)|P/E multiplikatori AIM|Bozor narxining sof foydaga nisbati ADTX|P/E multiplikatori GRI (GRI Bio Corporation)|P/E multiplikatori XORTX Corp XRTX|HIND - Narxning foydaga nisbati|Revelation Biosciences (REVB) - Narx-foyda koeffitsiyenti|INDP (Indaptus Therapeutics, Inc.) - Narx-foyda koeffitsiyenti|Scinai Immunotherapeutics Ltd (SCNI) - P/E multiplikatori|CALI (CalciMedica Inc) - P/E multiplikatori|affimed.com - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati allakos.com (ALLK)|P/E multiplikatori HOOKIPA Pharma, Inc. (HOOK)|IGM Biosciences Inc. - Narx-foyda koeffitsiyenti|iTeos Therapeutics, Inc. (ITOS) - Kapitalizatsiyaning foydaga nisbati|OCEA: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati TCBP (TC BioPharm (Holdings) PLC)|THRD: P/E multiplikatori